Editor’s Note: This article is a reprint. It was originally published October 6, 2018. Molds are microscopic fungi. To date, no one knows exactly how many species exist, but estimates range from tens of thousands to potentially more than 300,000.1 As demonstrated in the featured video, fungi are made of many cells and can sometimes… Read More »
From the earliest days of the COVID pandemic, the PCR test has been a source of unrelenting controversy, with experts repeatedly pointing out that it’s not a valid diagnostic and produces inordinate amounts of false positives. Importantly, a PCR test cannot distinguish between “live” viruses and inactive (noninfectious) viral particles. This is why it cannot… Read More »
As Biogen’s new Alzheimer’s drug Aduhelm makes headlines nearly every day—many covering the drug’s slower-than-expected uptake—one team of biopharma analysts is lowering its 2021 expectations for the med. Nonetheless, despite the drug sputtering out the gate, the team still sees a multibillion-dollar sales opportunity for the company in Alzheimer’s disease. Writing to investors Wednesday, analysts with RBC Capital Markets… Read More »
Maybe you occasionally forget appointments or social events, or lose your train of thought in a conversation. Maybe you’re feeling depressed or overwhelmed when making a decision. According to a online symptoms quiz from Biogen and Japanese partner Eisai, those are just a handful of signs of mild cognitive impairment (MCI), an early indication of… Read More »